Business in 2005

Sparks of inspiration and close relations with group companies keep Toyota's central research labs motoring along, as Ichiko Fuyuno reports.

The US biotechnology industry's lobby shop is at last making its mark. Its incoming president may have taken some flak for quitting Congress but, as Meredith Wadman discovers, he's relishing the change.

Looking for a fairy godmother to back a brilliant business idea? As Tony Reichhardt reports, a group of them probably meets for breakfast once a month at a hotel near you.

Companies and investors are starting to wake up to the powerful impact that global warming could have on their bottom line. Emma Marris reports.

Would-be entrants to the embryonic stem-cell business find access to the technology prohibitively expensive, Meredith Wadman reports.

Instead of the painstaking process of developing new drugs, one Boston-based company is making its mark by pairing up those we already have. Meredith Wadman reports.